港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

巨子生物

80.000

-0.200-0.25%

成交量：605.75万

成交额：4.87亿

市值：856.80亿

市盈率：35.73

高：81.800

开：80.450

低：78.850

收：80.200

数据加载中...

总览公司新闻公告

巨子生物盘中异动股价大涨5.00%

巨子生物大涨近10%创新高，胶原蛋白未来可期？

港股异动 | 巨子生物(02367)涨超10%创新高公司声明可复美产品未添加EGF 大单品驱动收入利润高增

可复美被质疑产品添加EGF，凌晨回应“未添加”，该品牌去年营收45亿元

港股异动 | 零售股走势强劲多点数智(02586)涨超20% 机构建议关注内需提振下投资机遇

巨子生物称可复美产品未添加人表皮生长因子

华熙的玻尿酸王者地位，正在被胶原蛋白反攻

华尔街见闻

突然暴涨18%！原因来了

巨子生物04月09日主力净流入1972万元散户资金抛售

巨子生物2024年净利增长42%，线上渠道增长显着

业绩大涨背后巨子生物的“财富密码”可持续吗？

中国商报网

巨子生物盘中异动大幅下挫5.89%

瑞银：降巨子生物(02367)目标价至80.6港元维持“买入”评级

《大行》瑞银：巨子生物(02367.HK)上财年利润率略逊预期降目标价至80.6元

阿斯达克财经

巨子生物盘中异动早盘股价大涨6.49%报64.850港元

巨子生物04月07日遭主力抛售1467万元

招银国际：内地医药行业有望在2025年继续迎来估值修复

巨子生物：可复美延续高增长可丽金提速胶原龙头潜力可期

点评 | 巨子生物：胶原棒势能超预期，可丽金线上高增拉动环比加速，关注新品迭代＆医美获批增量

刘章明消费产业...

资本风云｜巨子生物市值登顶，“挑战”珀莱雅当一哥？

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02367/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":80,"timestamp":1746000497031,"preClose":80.2,"halted":0,"volume":6057508,"delay":0,"floatShares":1071000000,"shares":1071000000,"eps":2.238772317307021,"marketStatus":"未开盘","change":-0.2,"latestTime":"04-30 16:08:17","open":80.45,"high":81.8,"low":78.85,"amount":486708527,"amplitude":0.036783,"askPrice":80,"askSize":103200,"bidPrice":79.75,"bidSize":200,"shortable":3,"etf":0,"ttmEps":2.1957630540829864,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":0,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":80.2,"dividendRate":0.012125,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"volumeRatio":0.906172421028747,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1071000000,"roa":"21.92%","roe":"35.88%","lyrEps":2.238772,"volumeRatio":0.906172421028747,"shares":1071000000,"dividePrice":0.97,"high":81.8,"amplitude":0.036783,"preClose":80.2,"low":78.85,"week52Low":35,"pbRate":"11.31","psRate":"14.51","week52High":81.8,"institutionHeld":0,"latestPrice":80,"committee":-0.996132,"eps":2.238772317307021,"divideRate":0.012125,"volume":6057508,"delay":0,"ttmEps":2.1957630540829864,"open":80.45,"prevYearClose":49.9,"prevWeekClose":77.1,"prevMonthClose":80,"prevQuarterClose":70.45,"fiveDayClose":75.65,"twentyDayClose":68,"sixtyDayClose":57.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527108231","title":"巨子生物盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527108231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527108231?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 09:47","pubTimestamp":1744681678,"startTime":"0","endTime":"0","summary":"2025年04月15日早盘09时47分，巨子生物股票出现波动，股价大幅上涨5.00%。截至发稿，该股报79.800港元/股，成交量215.79万股，换手率0.21%，振幅4.21%。巨子生物股票所在的生物技术行业中，整体涨幅为2.51%。其相关个股中，映恩生物-B、歌礼制药-B、巨子生物涨幅较大，振幅较大的相关个股有映恩生物-B、科伦博泰生物-B、和誉-B，振幅分别为39.11%、13.40%、6.53%。2022年，巨子生物登陆港交所，成为“重组胶原蛋白第一股”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415094759a45923cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415094759a45923cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2527154552","title":"巨子生物大涨近10%创新高，胶原蛋白未来可期？","url":"https://stock-news.laohu8.com/highlight/detail?id=2527154552","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527154552?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 18:53","pubTimestamp":1744627996,"startTime":"0","endTime":"0","summary":"4月14日，港股的“重组胶原蛋白第一股”巨子生物（02367.HK）大涨9.83%，创下上市以来的新高，目前公司报76港元/股，市值787.3亿港元。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202504_1/3fa7651a-0e70-40a9-b726-a6a627fc5f50.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202504_1/3fa7651a-0e70-40a9-b726-a6a627fc5f50.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67fce91c2308295289d7e0a9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["LU2488822045.USD","02367","BK1207","SG9999004311.SGD"],"gpt_icon":0},{"id":"2527897290","title":"港股异动 | 巨子生物(02367)涨超10%创新高 公司声明可复美产品未添加EGF 大单品驱动收入利润高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2527897290","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527897290?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 14:37","pubTimestamp":1744612639,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物盘中涨超10%，高见76.35港元创上市新高。4月12日凌晨，可复美在官方微博发布《致广大可复美消费者的一封信》，明确表示其旗下所有产品均未添加人表皮生长因子。财报显示，2024年，可复美单一品牌为巨子生物贡献八成营收，约为45亿元。因此，净利润率跌4个百分点至37.2%。该行相信，巨子生物产品组合成功扩展有助推动其长期快速增长，另外，四种注射产品目前正处于申请阶段，并即将商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367","BK1207","SG9999004311.SGD","LU2488822045.USD","EGF"],"gpt_icon":0},{"id":"2527977327","title":"可复美被质疑产品添加EGF，凌晨回应“未添加”，该品牌去年营收45亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527977327","media":"红星新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527977327?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 12:27","pubTimestamp":1744604820,"startTime":"0","endTime":"0","summary":"近日，有消费者向媒体控诉可复美在一款产品中添加了表皮生长因子，4月12日凌晨，可复美在官方微博发布《致广大可复美消费者的一封信》，明确表示其旗下所有产品均未添加人表皮生长因子。财报显示，2024年，可复美单一品牌为巨子生物贡献了八成左右的营收，约为45亿元。其中，可复美品牌在2024年的销售收入达到45.42亿元，同比增长约62.9%，占巨子生物总营收的82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041413120494d4a1a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041413120494d4a1a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367"],"gpt_icon":0},{"id":"2527750923","title":"港股异动 | 零售股走势强劲 多点数智(02586)涨超20% 机构建议关注内需提振下投资机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2527750923","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527750923?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 11:13","pubTimestamp":1744600392,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，零售股走势强劲，截至发稿，多点数智涨19.4%，报11.14港元；老铺黄金涨10.36%，报820港元；上美股份涨6.6%，报53.3港元；巨子生物涨7.08%，报74.1港元；泡泡玛特涨6.49%，报159.2港元；蜜雪集团涨4.34%，报437.2港元。消息面上，国信证券表示，国内政策和流动性宽松有望带动内需板块整体走势相对偏强。美容护理板块整体有望进一步受益国货替代加速，同时产品创新升级有望带来个股机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1207","LU0348767384.USD","02586","02145","SG9999004311.SGD","SG9999002950.SGD","BK1227","BK1544","BK1616","BK1233","LU0348766576.USD","BK1224","BK1109","LU0823426308.USD","LU0823426480.USD","02367","LU2488822045.USD"],"gpt_icon":1},{"id":"2527093025","title":"巨子生物称可复美产品未添加人表皮生长因子","url":"https://stock-news.laohu8.com/highlight/detail?id=2527093025","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527093025?lang=zh_cn&edition=fundamental","pubTime":"2025-04-12 17:52","pubTimestamp":1744451561,"startTime":"0","endTime":"0","summary":"中新经纬4月12日电 巨子生物表示，可复美产品未添加人表皮生长因子。秦女士曾自费将该产品送检，该款产品中检测出了其在产品说明书中并没有标注的成分：人表皮生长因子。大象新闻购买了秦女士使用的同款可复美产品送到第三方检测公司鉴定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041310244697365201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041310244697365201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","SG9999004311.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2526674176","title":"华熙的玻尿酸王者地位，正在被胶原蛋白反攻","url":"https://stock-news.laohu8.com/highlight/detail?id=2526674176","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526674176?lang=zh_cn&edition=fundamental","pubTime":"2025-04-12 13:39","pubTimestamp":1744436396,"startTime":"0","endTime":"0","summary":"打不过就加入","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/b8090aa4-cc4c-475a-9867-2c23f1fb40c4.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/b8090aa4-cc4c-475a-9867-2c23f1fb40c4.jpeg"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3745083","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3745083","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK1207","02367","LU2488822045.USD","SG9999004311.SGD"],"gpt_icon":0},{"id":"2526561640","title":"突然暴涨18%！原因来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2526561640","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526561640?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 20:47","pubTimestamp":1744289220,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　北交所“市值第一股”锦波生物自主研发生产的第三个采用生物新型材料——重组人源化胶原蛋白制备的三类植入医疗器械，近日正式获批。　　4月10日，锦波生物股价震荡上涨，最终以348.86元收盘，再创历史新高；收盘涨幅为17.87%，最新市值为309亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-04-10/doc-inessues2295915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1207","LU2488822045.USD","02367","SG9999004311.SGD"],"gpt_icon":0},{"id":"2526323173","title":"巨子生物04月09日主力净流入1972万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2526323173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526323173?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 16:16","pubTimestamp":1744186605,"startTime":"0","endTime":"0","summary":"04月09日, 巨子生物股价涨5.04%，报收67.75元，成交金额3.89亿元，换手率0.57%，振幅11.94%，量比1.11。巨子生物今日主力资金净流入1972万元，上一交易日主力净流出3669万元。该股近5个交易日下跌5.61%，主力资金累计净流出3805万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出7242万元，其中净流出天数为12日。该股主力净额占比0.03%，港股市场排名261/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409170946a6b53a62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409170946a6b53a62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","SG9999004311.SGD","02367"],"gpt_icon":0},{"id":"2526766330","title":"巨子生物2024年净利增长42%，线上渠道增长显着","url":"https://stock-news.laohu8.com/highlight/detail?id=2526766330","media":"群益证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526766330?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 16:15","pubTimestamp":1744186524,"startTime":"0","endTime":"0","summary":"HK)在2024年表现出色，实现营收55.4亿元人民币，同比增长57.2%，归母净利润达21.5亿元人民币，同比增长42.1%。经调整利润为21.5亿元人民币，同比增长46.5%，符合市场预期。此外，公司拟派发每股0.6021元人民币的股息及特别股息0.5921元人民币，以当前股价计算，股息率约为2.1%。其中，“可复美”品牌收入达45.4亿元人民币，同比增长62.9%，主要得益于线上渠道的高速增长。2024年销售费用率为36.3%，同比增加3.2个百分点，研发费用率则保持稳定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409165318a453841c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409165318a453841c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","LU2488822045.USD","SG9999004311.SGD"],"gpt_icon":0},{"id":"2526870909","title":"业绩大涨背后 巨子生物的“财富密码”可持续吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2526870909","media":"中国商报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526870909?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 10:17","pubTimestamp":1744165043,"startTime":"0","endTime":"0","summary":"不过，仍有市场声音认为，重组胶原蛋白一直是巨子生物的“财富密码”，但是其已上市的化妆品技术门槛低、同质化竞争严重。业绩大涨仍存隐忧根据巨子生物发布的财报，2024年，巨子生物营收达55.39亿元，同比增长57.2%；净利润达20.62亿元，同比增长42.1%。国家药监局官网显示，目前，巨子生物注册备案的均是敷料类产品。此外，巨子生物超八成的收入来自以重组胶原蛋白为基础的护肤品牌可复美。也有投资机构上调了巨子生物的目标价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040910181094d03bea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040910181094d03bea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2526874857","title":"巨子生物盘中异动 大幅下挫5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526874857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526874857?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 09:30","pubTimestamp":1744162222,"startTime":"0","endTime":"0","summary":"2025年04月09日早盘09时30分，巨子生物股票出现异动，股价大幅下挫5.89%。截至发稿，该股报60.700港元/股，成交量4.72万股，换手率0.00%，振幅2.87%。巨子生物股票所在的生物技术行业中，整体跌幅为2.93%。其相关个股中，云康集团、华康生物医学、中生北控生物科技涨幅较大，振幅较大的相关个股有科伦博泰生物-B、泰格医药、同源康医药-B，振幅分别为7.87%、6.76%、6.04%。但巨子生物却继续高增，不仅营收突破50亿元，同比增速更是达到57.2%，为5年来新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409093024a4531973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409093024a4531973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","LU2488822045.USD","SG9999004311.SGD","BK1207"],"gpt_icon":0},{"id":"2525340908","title":"瑞银：降巨子生物(02367)目标价至80.6港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2525340908","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525340908?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 14:16","pubTimestamp":1744093009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，巨子生物(02367)2024财年业绩与该行预测基本一致，惟利润率略低于预期。瑞银表示，对巨子生物销售增长保持乐观，但在经营环境挑战及产品或渠道组合转变下，对公司利润率表现转为更保守。该行将巨子生物目标价由82港元下调至80.6港元，并认为该股具有上升潜力，主要考虑到其2024至2026财年销售及盈利复合年均增长率预计分别为32%及22%，维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1275269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"2525783179","title":"《大行》瑞银：巨子生物(02367.HK)上财年利润率略逊预期 降目标价至80.6元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525783179","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525783179?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 14:02","pubTimestamp":1744092120,"startTime":"0","endTime":"0","summary":"瑞银发表研报指，巨子生物(02367.HK) 2024财年业绩与该行预测基本一致，惟利润率略低于预期。瑞银表示，对巨子生物销售增长保持乐观，但在经营环境挑战及产品或渠道组合转变下，对公司利润率表现转为更保守。该行将巨子生物目标价由82元下调至80.6元，并认为该股具有上升潜力，主要考虑到其2024至2026财年销售及盈利复合年均增长率预计分别为32%及22%，维持“买入”评级。(js/w)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221209170600934_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221209170600934_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1432332/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367"],"gpt_icon":0},{"id":"2525181000","title":"巨子生物盘中异动 早盘股价大涨6.49%报64.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525181000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525181000?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 09:30","pubTimestamp":1744075810,"startTime":"0","endTime":"0","summary":"2025年04月08日早盘09时30分，巨子生物股票出现波动，股价快速拉升6.49%。截至发稿，该股报64.850港元/股，成交量1.98万股，换手率0.00%，振幅5.25%。资金方面，该股资金流入13.961万港元，流出6.192万港元。巨子生物股票所在的生物技术行业中，整体涨幅为1.74%。其相关个股中，来凯医药-B、加科思-B、腾盛博药-B涨幅较大，振幅较大的相关个股有来凯医药-B、腾盛博药-B、巨子生物，振幅分别为8.57%、6.33%、5.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040809301297314587&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040809301297314587&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2525945100","title":"巨子生物04月07日遭主力抛售1467万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525945100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525945100?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 16:17","pubTimestamp":1744013840,"startTime":"0","endTime":"0","summary":"04月07日, 巨子生物股价跌14.71%，报收60.90元，成交金额4.10亿元，换手率0.63%，振幅10.08%，量比1.41。巨子生物今日主力资金净流出1467万元，连续4日净流出，上一交易日主力净流出292万元。该股近5个交易日下跌11.54%，主力资金累计净流出347万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1038万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407171331a6b270f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407171331a6b270f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","LU2488822045.USD","02367","BK1207"],"gpt_icon":0},{"id":"2525691330","title":"招银国际：内地医药行业有望在2025年继续迎来估值修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2525691330","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525691330?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 14:42","pubTimestamp":1744008148,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，受益于国内药品价格政策优化、国内宏观环境改善，以及创新药和器械出海持续增长，内地医药行业有望在2025年继续迎来估值修复。丙类医保目录年内即将落地，创新药将获得更好的支付环境。医疗设备招标加速复苏，将推动国产医疗设备企业盈利复苏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","LU0196878994.USD","LU0588546209.SGD","LU2488822045.USD","BK1583","06160","LU2125910500.SGD","LU2328871848.SGD","LU1046422090.SGD","LU2045819591.USD","LU0052750758.USD","LU1969619763.USD","02367","06990","BK1500","BK1593","LU0320764599.SGD","BK1576","01530","BK1207","SG9999004311.SGD","BK1141","LU0307460666.USD","BK1161","LU0708995583.HKD","LU2242644610.SGD","01801","BK1589","BK1588"],"gpt_icon":0},{"id":"2525050523","title":"巨子生物：可复美延续高增长 可丽金提速 胶原龙头潜力可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2525050523","media":"中泰证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525050523?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 00:00","pubTimestamp":1743955200,"startTime":"0","endTime":"0","summary":"巨子生物发布24 年财务报告：1）2024 年：公司24 年营业收入55.4 亿元，YOY+57%；经调整净利润21.5 亿元，YOY+46.5%。收入拆分：可复美维持高增长，可丽金24H2 提速。其中，可复美、可丽金24 下半年收入分别为24.7 亿元和4.4 亿元，YOY 分别增长58.4%以及50.1%。新品焦点面霜通过3R 光奕律时修护体系实现精准人群触达，双十一期间跻身天猫修复面霜国货TOP2 及抖音胶原蛋白霜好评榜TOP1，大单品潜力逐步显现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407131625a4506171&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407131625a4506171&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1207","02367","SG9999004311.SGD"],"gpt_icon":0},{"id":"2525709905","title":"点评 | 巨子生物：胶原棒势能超预期，可丽金线上高增拉动环比加速，关注新品迭代＆医美获批增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2525709905","media":"刘章明消费产业...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525709905?lang=zh_cn&edition=fundamental","pubTime":"2025-04-06 23:15","pubTimestamp":1743952531,"startTime":"0","endTime":"0","summary":"本文来自方正证券研究所《巨子生物公司点评报告：胶原棒势能超预期，可丽金线上高增拉动环比加速，关注新品迭代＆医美获批增量》，欲了解报告详情，请阅读报告原文。收入拆分：双品牌多渠道高增，25Q1势能延续按品牌：可复美胶原棒势能超预期，焦点稳步拓展放量，可丽金线上驱动增长加速。③可丽金增长超预期，线上高速增长有望拉动整体增长加速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407020205a44fdb25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407020205a44fdb25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999004311.SGD","BK1207","02367"],"gpt_icon":0},{"id":"2525003794","title":"资本风云｜巨子生物市值登顶，“挑战”珀莱雅当一哥？","url":"https://stock-news.laohu8.com/highlight/detail?id=2525003794","media":"子弹财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525003794?lang=zh_cn&edition=fundamental","pubTime":"2025-04-05 19:00","pubTimestamp":1743850806,"startTime":"0","endTime":"0","summary":"而到了今年，截至4月3日，巨子生物市值已超739亿港元，是珀莱雅的两倍多。随着营收增长，2024年上半年巨子生物净利润达到9.83亿元，超过同期珀莱雅的7.02亿元。截至4月2日，巨子生物市盈率33倍，而珀莱雅则是22倍。净利润比珀莱雅高，估值倍数也比珀莱雅高，综合因素作用下，巨子生物市值超700亿港元，已是珀莱雅的2倍多。根据巨子生物招股书，四款在研产品中前两款预计在2024年第一季度获批取证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405190642a6b091da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405190642a6b091da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","LU2488822045.USD","02367","BK1207"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盘后","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盘后","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4737,"buy":0.5263,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1745337600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-04-30","current":37.231772,"percent":0.881384,"low":18.546195,"twenty":25.868985,"median":29.344363,"eighty":34.133202,"high":60.214956,"avg":30.50703,"sd":6.56524,"marketCap":81890693200},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600},{"date":"2025-04-11","current":32.158951,"twenty":25.847354,"median":29.194481,"eighty":33.675182,"marketCap":70369756800},{"date":"2025-04-17","current":33.426462,"twenty":25.850275,"median":29.270028,"eighty":33.693297,"marketCap":73318778400},{"date":"2025-04-25","current":35.713683,"twenty":25.864757,"median":29.297766,"eighty":33.896985,"marketCap":78403298400},{"date":"2025-04-30","current":37.231772,"twenty":25.868985,"median":29.344363,"eighty":34.133202,"marketCap":81890693200}],"updateTime":1746120331715}}}